Community First Health Plans will begin enforcing Medicare-aligned coverage and billing requirements for low-dose CT lung cancer screenings on June 1, 2026. Coverage is limited to patients aged 50–77 ...
As the documentation burden grows and patient portals overflow, oncologists are hoping to preserve what matters most — the ...
The FY 2026 ICD-10-CM guidelines bring refined updates for coding digestive system diseases, helping improve accuracy, compliance, and reimbursement. Coders must manage detailed rules, from ...
ImmunityBio IBRX enters 2026 with a commercial story that is unusually concentrated. Anktiva is the company’s first marketed ...
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its ...
A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding ...
The American College of Physicians is changing its guidelines for when women should get mammography screenings. The guidelines make screenings more personalized based on age, risk factors, breast ...
NEW DELHI: Breast cancer, the most common cancer in women globally, including in India, where it tops women-centric cancers, can now be predicted early after new global guidelines recommending ...
Sensible’ recommendations support biennial screening from age 50 to 74, with individualized decision-making for women below ...
Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...
In his emotional account, Desai shared that while the app was not perfect, it played a crucial role in helping his mother navigate her final months with greater dignity and control. (Representational ...
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug ...